Estradiol Nasal Spray for Patulous Eustachian Tube (PET)
Estradiol 0.5 mg/0.1 mL Nasal Spray in MucoLox™
Quantity: 10 mL
Price: Call 833.540.3500 or login to the Practitioner Portal for pricing.
Sig:Tilt head to side and aim 2 sprays in nostril toward affected Eustachian tube(s) twice daily. Lie down for 10 minutes afterward.
The FDA does not review any compounded medication for safety or efficacy.
What is Estradiol Nasal Spray?
Estradiol 0.5 mg/0.1 mL nasal spray is a compounded, prescription-only medication prepared by a pharmacy for patient-specific use. It contains estradiol, a form of estrogen, formulated into a nasal spray for intranasal administration.
Each 0.1 mL spray delivers 0.5 mg of estradiol, allowing for precise, localized dosing as directed by the prescriber.
In ENT practice, this formulation is sometimes used in the management of patulous Eustachian tube (PET). The goal of therapy is to support mucosal thickening and increased tissue fullness around the Eustachian tube opening, which may help reduce symptoms such as autophony and aural fullness.
Download our Estradiol Nasal Spray for Patulous Eustachian Tube (PET) Flyer
Clinical Scenarios Where ENTs Explore Estradiol Nasal Spray
ENT specialists may consider compounded estradiol nasal spray in select patients with patulous Eustachian tube (PET), particularly when symptoms are persistent and conservative measures have not provided adequate relief.
Common clinical scenarios include:
- Persistent Symptomatic PET – Patients experiencing ongoing autophony, aural fullness, or audible breathing despite first-line strategies (hydration, positional changes, saline) may be considered for localized therapies such as estradiol nasal spray.
- Weight Loss–Associated PET – PET is frequently reported after significant or rapid weight loss, where loss of peritubal fat reduces natural support around the Eustachian tube. Estradiol may be explored to help restore mucosal and tissue fullness.
- Intermittent or Positional PET – Patients whose symptoms worsen with upright posture or physical activity may benefit from therapies aimed at improving dynamic closure of the Eustachian tube.
- Patients Seeking Non-Procedural Options – Before moving to procedural interventions (e.g., injections, implants, or surgical approaches), ENTs may trial non-invasive, locally acting therapies such as compounded nasal sprays.
- Adjunct to Other PET Management Strategies – Estradiol nasal spray may be used alongside other supportive approaches as part of a multimodal management plan, depending on provider preference and patient response.
Use of compounded estradiol nasal spray should always be based on clinical judgment and prescribed for an individual patient after appropriate evaluation.
Mechanism of Action
Estrogen delivered to the Eustachian tube by a nasal spray is believed to:
Initiate tissue swelling from jet force
Increase local mucosal thickness and vascular engorgement
Reduce Eustachian tube resting patency
This localized effect is precisely what makes intranasal estrogen therapy attractive for PET management.
Advantages of Compounded Estradiol Nasal Spray
- Single, well-characterized active ingredient
- Non–animal-derived source, avoiding ethical concerns associated with equine estrogens
- Customizable formulation
- Mucoadhesive vehicle (MucoLox™) increases contact time
- Targeted local delivery
Clinical Considerations
- Dosing frequency may be individualized based on patient response
- Counsel patients regarding possible local irritation
- Systemic absorption must be considered and patients should be monitored for hormone associated symptoms
- Please document “PET” diagnosis on the prescription
Other Applications
Estradiol nasal solution may also be prescribed for Hereditary Hemorrhagic Telangiectasia (HHT). For HHT patients, the medication is dispensed in a dropper formulation rather than a spray due to epistaxis concerns. Please document “HHT” diagnosis and specify “nasal drops” on the prescription.
Why ENTs Choose Massey Drugs
ENT-focused compounding expertise for otic, nasal, and oral therapies
Flexible dosage forms including drops, sprays, powders, capsules, and rinses
Fast 24–48 hour turnaround to keep treatment on schedule
FREE Ground Shipping on all ENT compounded medications
NABP accredited compounding pharmacy
Direct pharmacist access for formulation and clinical support
Transparent pricing available through the Practitioner Portal
States We Serve
Massey Drugs is licensed to ship ENT compounds to patients in: Alabama, Tennessee, Mississippi, Louisiana, Georgia, Florida, North Carolina, South Carolina, Kentucky, Illinois, Indiana, Ohio, Pennsylvania, New York, Connecticut, and Texas.
How to Prescribe Estradiol Nasal Spray
Download Rx Blank from the Practitioner Portal and send to Massey Drugs:
FAX: 800.637.2601
Phone: 833.540.3500
OR
e-Scribe: NPI#: 1295756245 | NCPCP#: 0127553
Massey Drugs | Cloverdale Road
Upon receipt of prescription, Massey Drugs contacts the patient to confirm shipping address and credit card payment.
Medication ships to patient in 24-48 hours once processed.
Massey Drugs provides competitively priced compounded medications with transparent, prescriber-accessible pricing. All compound pricing can be viewed in our Practitioner Portal so costs can be communicated to patients before prescribing.
Speak with a Pharmacist
If you have questions about this compound, formulation options, or whether this therapy may be appropriate for a specific clinical scenario, our pharmacists are available to consult. Call 833-540-3500 or contact us.
Frequentley Asked Questions
Is estradiol nasal spray FDA-approved for this use?
No. Estradiol nasal spray for PET is not an FDA-approved product or indication. It is a compounded medication prepared by a 503A pharmacy pursuant to a valid prescription. Prescribers may choose this option when a commercially available alternative does not meet the patient’s needs.
How long does it typically take to see a response?
Response time can vary by patient. Some patients may notice changes in symptoms within a few weeks, while others may require a longer trial period. Duration of therapy and response should be evaluated and adjusted by the prescriber based on clinical outcomes
Are there systemic effects with intranasal estradiol?
While this formulation is intended for localized nasal use, some systemic absorption is possible with any estrogen therapy. The extent can vary based on dosing, frequency, and patient-specific factors. Prescribers should consider individual risk factors and clinical history when determining appropriateness.